Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ARRHYTHMIA SUPPRESSION TRIAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 84 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Darpo, B
      Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Brass, EP
      Implementation of a data and safety monitoring program in a General Clinical Research Center

      JOURNAL OF INVESTIGATIVE MEDICINE
    3. Rogers, KC; Wolfe, DA
      Ibutilide: A class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter

      JOURNAL OF EMERGENCY MEDICINE
    4. Gerlach, U
      I-Ks channel blockers: potential antiarrhythmic agents

      DRUGS OF THE FUTURE
    5. Gerlach, U; Brendel, J; Lang, HJ; Paulus, EF; Weidmann, K; Bruggemann, A; Busch, AE; Suessbrich, H; Bleich, M; Greger, R
      Synthesis and activity of novel and selective I-Ks-channel blockers

      JOURNAL OF MEDICINAL CHEMISTRY
    6. Myerburg, RJ; Mitrani, R; Interian, A; Simmons, J; Kloosterman, M; Castellanos, A
      The interpretation and clinical application of data from trials on sudden cardiac death

      JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
    7. Larsen, JA; Kadish, AH; Schwartz, JB
      Proper use of antiarrhythmic therapy for reduction of mortality after myocardial infarction

      DRUGS & AGING
    8. Hastings, HM; Fenton, FH; Evans, SJ; Hotomaroglu, O; Geetha, J; Gittelson, K; Nilson, J; Garfinkel, A
      Alternans and the onset of ventricular fibrillation

      PHYSICAL REVIEW E
    9. Da Costa, A; Chalvidan, T; Belounas, A; Messier, M; Viallet, M; Mansour, H; Lamaison, D; Djiane, P; Isaaz, K
      Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: Role of QTdispersion and left ventricular function

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    10. Gonska, BD
      Pharmacological therapy of ventricular tachycardias

      ZEITSCHRIFT FUR KARDIOLOGIE
    11. Nakagawa, K; Ishizaki, T
      Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine

      PHARMACOLOGY & THERAPEUTICS
    12. Conti, CR
      What is structural heart disease?

      CLINICAL CARDIOLOGY
    13. Trujillo, TC; Nolan, PE
      Antiarrhythmic agents - Drug interactions of clinical significance

      DRUG SAFETY
    14. Haverkamp, W; Breithardt, G
      Heart rate as a target for the prevention of sudden death

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    15. Olgin, JE; Viskin, S
      Management of intermittent atrial fibrillation: Drugs to maintain sinus rhythm

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    16. Myerburg, RJ; Kloosterman, M; Yamamura, K; Mitrani, R; Interian, A; Castellanos, A
      The case for inpatient initiation of antiarrhythmic therapy

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    17. Crawford, MH; Bernstein, SJ; Deedwania, PC; DiMarco, JP; Ferrick, KJ; Garson, A; Green, LA; Greene, HL; Silka, MJ; Stone, PH; Tracy, CM; Gibbons, RJ; Alpert, JS; Eagle, KA; Gardner, TJ; Garson, A; Gregoratos, G; Russell, RO; Ryan, TJ; Smith, SC
      ACC/AHA Guidelines for Ambulatory Electrocardiography - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines - (Committee to revise the guidelines for ambulatory electrocardiography) - Developed in collaboration with the North American society for pacing and electrophysiology

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    18. Buxton, AE; Lee, KL; Fisher, JD; Josephson, ME; Prystowsky, EN; Hafley, G
      A randomized study of the prevention of sudden death in patients with coronary artery disease

      NEW ENGLAND JOURNAL OF MEDICINE
    19. JAHANGIR A; STANTON MS; HAMMILL SC; SHEN WK
      CLASS-I AND CLASS-III ANTIARRHYTHMIC DRUGS - PRACTICAL CONSIDERATIONSFOR SAFE, EFFECTIVE USE

      Formulary
    20. NACCARELLI GV; WOLBRETTE DL; DELLORFANO JT; PATEL HM; LUCK JC
      A DECADE OF CLINICAL-TRIAL DEVELOPMENTS IN POSTMYOCARDIAL INFARCTION,CONGESTIVE-HEART-FAILURE, AND SUSTAINED VENTRICULAR TACHYARRHYTHMIA PATIENTS - FROM CAST TO AVID AND BEYOND

      Journal of cardiovascular electrophysiology
    21. CLEOPHAS TJM
      DEPRESSION AND MYOCARDIAL-INFARCTION - IMPLICATIONS FOR MEDICAL PROGNOSIS AND OPTIONS FOR TREATMENT

      Netherlands journal of medicine
    22. CALIFF RM; GRANGER CB
      HYPERTENSION AND DIABETES AND THE FOSINOPRIL VERSUS AMLODIPINE CARDIOVASCULAR EVENTS TRIAL (FACET) - MORE AMMUNITION AGAINST SURROGATE END-POINTS

      Diabetes care
    23. ROOSE SP; LAGHRISSITHODE F; KENNEDY JS; NELSON JC; BIGGER JT; POLLOCK BG; GAFFNEY A; NARAYAN M; FINKEL MS; MCCAFFERTY J; GERGEL I
      COMPARISON OF PAROXETINE AND NORTRIPTYLINE IN DEPRESSED-PATIENTS WITHISCHEMIC-HEART-DISEASE

      JAMA, the journal of the American Medical Association
    24. VANGELDER IC; BRUGEMANN J; CRIJNS HJGM
      CURRENT TREATMENT RECOMMENDATIONS IN ANTIARRHYTHMIC THERAPY

      Drugs
    25. KIRCHHOF PF; FABRITZ CL; FRANZ MR
      POSTREPOLARIZATION REFRACTORINESS VERSUS CONDUCTION SLOWING CAUSED BYCLASS-I ANTIARRHYTHMIC DRUGS - ANTIARRHYTHMIC AND PROARRHYTHMIC EFFECTS

      Circulation
    26. MYERBURG RJ; MITRANI R; INTERIAN A; CASTELLANOS A
      INTERPRETATION OF OUTCOMES OF ANTIARRHYTHMIC CLINICAL-TRIALS - DESIGN-FEATURES AND POPULATION-IMPACT

      Circulation
    27. STAFFORD RS; ROBSON DC; MISRA B; RUSKIN J; SINGER DE
      RATE CONTROL AND SINUS RHYTHM MAINTENANCE IN ATRIAL-FIBRILLATION - NATIONAL TRENDS IN MEDICATION USE, 1980-1990

      Archives of internal medicine
    28. ROOSE SP; GLASSMAN AH; ATTIA E; WOODRING S; GIARDINA EGV; BIGGER JT
      CARDIOVASCULAR EFFECTS OF FLUOXETINE IN DEPRESSED-PATIENTS WITH HEART-DISEASE

      The American journal of psychiatry
    29. RODEN DM
      MECHANISMS AND MANAGEMENT OF PROARRHYTHMIA

      The American journal of cardiology
    30. PRATT CM; CAMM AJ; COOPER W; FRIEDMAN PL; MACNEIL D; MOULTON KM; PITT B; SCHWARTZ PJ; VELTRI EP; WALDO AL
      MORTALITY IN THE SURVIVAL WITH ORAL D-SOTALOL (SWORD) TRIAL - WHY DIDPATIENTS DIE

      The American journal of cardiology
    31. MACKSTALLER LL; ALPERT JS
      ATRIAL-FIBRILLATION - A REVIEW OF MECHANISM, ETIOLOGY, AND THERAPY

      Clinical cardiology
    32. MARINCHAK RA; RIALS SJ; FILART RA; KOWEY PR
      THE TOP 10 FALLACIES OF NONSUSTAINED VENTRICULAR-TACHYCARDIA

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    33. RAHIMTOOLA SH
      THE TREATMENT OF ATRIAL-FIBRILLATION - PHARMACOLOGICAL AND NONPHARMACOLOGIC STRATEGIES

      Current problems in cardiology
    34. LIEBSON PR; KLEIN LW
      THE NON-Q-WAVE MYOCARDIAL-INFARCTION REVISITED - 10 YEARS LATER

      Progress in cardiovascular diseases
    35. MCALISTER FA; TEO KK
      ANTIARRHYTHMIC THERAPIES FOR THE PREVENTION OF SUDDEN CARDIAC DEATH

      Drugs
    36. CRAGUN KT; JOHNSON SB; PACKER DL
      BETA-ADRENERGIC AUGMENTATION OF FLECAINIDE-INDUCED CONDUCTION SLOWINGIN CANINE PURKINJE-FIBERS

      Circulation
    37. CAMPBELL TJ
      THE PLACE OF AMIODARONE - AN OVERVIEW OF THE 4 RECENT LARGE CONTROLLED TRIALS

      Australian and New Zealand Journal of Medicine
    38. MAISEL WH; KUNTZ KM; REIMOLD SC; LEE TH; ANTMAN EM; FRIEDMAN PL; STEVENSON WG
      RISK OF INITIATING ANTIARRHYTHMIC DRUG-THERAPY FOR ATRIAL-FIBRILLATION IN PATIENTS ADMITTED TO A UNIVERSITY HOSPITAL

      Annals of internal medicine
    39. HOHNLOSER SH
      PROARRHYTHMIA WITH CLASS-III ANTIARRHYTHMIC DRUGS - TYPES, RISKS, ANDMANAGEMENT

      The American journal of cardiology
    40. ANDERSON JL; PRATT CM; WALDO AL; KARAGOUNIS LA
      IMPACT OF THE FOOD-AND-DRUG-ADMINISTRATION APPROVAL OF FLECAINIDE ANDENCAINIDE ON CORONARY-ARTERY DISEASE MORTALITY - PUTTING DEADLY MEDICINE TO THE TEST

      The American journal of cardiology
    41. COBBE SM
      CLASS-III ANTIARRHYTHMICS - PUT TO THE SWORD

      HEART
    42. LATINI R; MAGNOLFI G; ZORDAN R; PADRINI R; PIOVAN D; PECORARI T; BOTTAZZI L; GUIDUCCI U
      ANTIARRHYTHMIC DRUG PLASMA-CONCENTRATIONS IN AMBULATORY PATIENTS

      The Annals of pharmacotherapy
    43. BREMBILLAPERROT B; JACQUEMIN L; DELACHAISE AT; BEURRIER D
      PROGRAMMED VENTRICULAR STIMULATION AFTER MYOCARDIAL-INFARCTION DOES NOT HELP REDUCE THE RISK OF VENTRICULAR EVENTS

      Cardiovascular drugs and therapy
    44. MITCHELL LB
      USE OF THE NEWER ANTIARRHYTHMIC DRUGS IN PATIENTS WITH SUPRAVENTRICULAR TACHYARRHYTHMIAS - LETS NOT THROW OUT THE BABY WITH THE BATH WATER

      Canadian journal of cardiology
    45. ZEHENDER M; JUST H
      BETABLOCKING AGENTS IN PATIENTS WITH CORO NARY-ARTERY DISEASE AND AT RISK FOR SUDDEN CARDIAC DEATH - WITH CONSIDERATIONS OF CARVEDILOL

      Zeitschrift fur Kardiologie
    46. ROSENBERG WMC; SACKETT DL
      ON THE NEED FOR EVIDENCE-BASED MEDICINE

      Therapie
    47. ANDERSON KP; BIGGER JT; FREEDMAN RA
      ELECTROCARDIOGRAPHIC PREDICTORS IN THE ESVEM TRIAL - UNSUSTAINED VENTRICULAR-TACHYCARDIA, HEART PERIOD VARIABILITY, AND THE SIGNAL-AVERAGEDELECTROCARDIOGRAM

      Progress in cardiovascular diseases
    48. GARRISON GL; BERLIN KD; SCHERLAG BJ; LAZZARA R; PATTERSON E; FAZEKAS T; SANGIAH S; CHEN CL; SCHUBOT FD; VANDERHELM D
      NOVEL 3,7-DIHETERABICYCLO[3.3.1]NONANES THAT POSSESS PREDOMINANT CLASS-III ANTIARRHYTHMIC ACTIVITY IN 1-4 DAY POST INFARCTION DOG-MODELS - X-RAY-DIFFRACTION ANALYSIS OF BENZOYL]-7-ISOPROPYL-3,7-DIAZABICYCLO[3.3.1]NONANE DIHYDROPERCHLORATE

      Journal of medicinal chemistry
    49. RODEN DM
      IS THERE A NEED FOR NEW ANTIARRHYTHMIC DRUGS

      Archives des maladies du coeur et des vaisseaux
    50. RODEN DM
      IONIC MECHANISMS FOR PROLONGATION OF REFRACTORINESS AND THEIR PROARRHYTHMIC AND ANTIARRHYTHMIC CORRELATES

      The American journal of cardiology
    51. SACKETT DL; ROSENBERG WMC
      ON THE NEED FOR EVIDENCE-BASED MEDICINE

      Health economics
    52. HOHNLOSER SH; SINGH BN
      PROARRHYTHMIA WITH CLASS-III ANTIARRHYTHMIC DRUGS - DEFINITION, ELECTROPHYSIOLOGIC MECHANISMS, INCIDENCE, PREDISPOSING FACTORS, AND CLINICAL IMPLICATIONS

      Journal of cardiovascular electrophysiology
    53. EPSTEIN AE
      DRUGS VERSUS DEVICES - CONTEMPORARY PRACTICE IN LIGHT OF CONTEMPORARYTRIALS

      Journal of cardiovascular electrophysiology
    54. SACKETT DL; ROSENBERG WMC
      ON THE NEED FOR EVIDENCE-BASED MEDICINE

      Journal of public health medicine
    55. EDWARDS PR
      CHOOSING ANTIHYPERTENSIVE TREATMENT MODELS OF DISEASE V RCTS

      South African medical journal
    56. SACKETT DL; ROSENBERG WMC
      THE NEED FOR EVIDENCE-BASED MEDICINE

      Journal of the Royal Society of Medicine
    57. TISDALE JE; FOLLIN SL; ORDELOVA A; WEBB CR
      RISK-FACTORS FOR THE DEVELOPMENT OF SPECIFIC NONCARDIOVASCULAR ADVERSE-EFFECTS ASSOCIATED WITH AMIODARONE

      Journal of clinical pharmacology
    58. HAMDAN M; SCHEINMAN M
      CURRENT APPROACHES IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS

      The Medical clinics of North America
    59. JOHNSON RE; SILVER PJ; BECKER R; BIRSNER NC; BOHNET EA; BRIGGS GM; BUSACCA CA; CANNIFF P; CARABATEAS PM; CHADWICK CC; DAMBRA T; DUNDORE RL; DUNG JS; EZRIN AM; GORCZYCA W; HABEEB PG; KRAFTE PHDS; PILLING GM; OCONNOR B; SAINDANE MT; SCHLEGEL DC; STANKUS GP; SWESTOCK J; VOLBERG WA
      SULFONAMIDOPHENYL)-1-PHENYL-1H-2,4-BENZODIAZEPINES - A NOVEL CLASS-III ANTIARRHYTHMIC AGENTS

      Journal of medicinal chemistry
    60. OMOIGUI NA; MARCUS FI; MASON JW; HAHN EA; HARTZ VL; HLATKY MA
      COST OF INITIAL THERAPY IN THE ELECTROPHYSIOLOGICAL STUDY VERSUS ECG MONITORING TRIAL (ESVEM)

      Circulation
    61. GREENBERG HM; DWYER EM; HOCHMAN JS; STEINBERG JS; ECHT DS; PETERS RW
      INTERACTION OF ISCHEMIA AND ENCAINIDE FLECAINIDE TREATMENT - A PROPOSED MECHANISM FOR THE INCREASED MORTALITY IN CAST-I/

      British Heart Journal
    62. AVANZINI F; LATINI R; MAGGIONI A; COLOMBO F; SANTORO E; FRANZOSI MG; TOGNONI G
      ANTIARRHYTHMIC DRUG PRESCRIPTION IN PATIENTS AFTER MYOCARDIAL-INFARCTION IN THE LAST DECADE - EXPERIENCE OF THE -STUDIO-DELLA-SOPRAVVIVENZA-NELLINFARTO-MIOCARDICO (GISSI)

      Archives of internal medicine
    63. KENDALL MJ; LYNCH KP; HJALMARSON A; KJEKSHUS J
      BETA-BLOCKERS AND SUDDEN CARDIAC DEATH

      Annals of internal medicine
    64. WALDO AL; CAMM AJ; DERUYTER H; FRIEDMAN PL; MACNEIL DJ; PITT B; PRATT CM; RODDA BE; SCHWARTZ PJ
      SURVIVAL WITH ORAL D-SOTALOL IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RATIONALE, DESIGN, AND METHOD (THESWORD TRIAL)

      The American journal of cardiology
    65. GLASSMAN AH; STAGE KB
      DEPRESSED-PATIENTS WITH CARDIOVASCULAR-DISEASE - TREATMENT CONSIDERATIONS

      CNS DRUGS
    66. RODEN DM; TAMKUN MM
      TOWARD A MOLECULAR VIEW OF CARDIAC ARRHYTHMOGENESIS

      Trends in cardiovascular medicine
    67. FRANZ MR
      BRIDGING THE GAP BETWEEN BASIC AND CLINICAL ELECTROPHYSIOLOGY - WHAT CAN BE LEARNED FROM MONOPHASIC ACTION-POTENTIAL RECORDINGS

      Journal of cardiovascular electrophysiology
    68. REIFFEL JA; ESTES NAM; WALDO AL; PRYSTOWSKY EN; DIBIANCO R
      A CONSENSUS REPORT ON ANTIARRHYTHMIC DRUG-USE

      Clinical cardiology
    69. KOLLER B; FRANZ MR
      NEW CLASSIFICATION OF MORICIZINE AND PROPAFENONE BASED ON ELECTROPHYSIOLOGIC AND ELECTROCARDIOGRAPHIC DATA FROM ISOLATED RABBIT HEART

      Journal of cardiovascular pharmacology
    70. KOLLER B; FRANZ MR
      NEW CLASSIFICATION OF MORICIZINE AND PROPAFENONE BASED ON ELECTROPHYSIOLOGIC AND ELECTROCARDIOGRAPHIC DATA FROM ISOLATED RABBIT HEART

      Journal of cardiovascular pharmacology
    71. LAWSON CS; COLTART DJ
      RECENT ADVANCES IN CARDIOLOGY

      Postgraduate medical journal
    72. RODEN DM
      DRUG-THERAPY - RISKS AND BENEFITS OF ANTIARRHYTHMIC THERAPY

      The New England journal of medicine
    73. SUGIYAMA A; MOTOMURA S; HASHIMOTO K
      UTILIZATION OF AN ISOLATED, BLOOD-PERFUSED CANINE PAPILLARY-MUSCLE PREPARATION AS A MODEL TO ASSESS EFFICACY AND ADVERSITY OF CLASS-I ANTIARRHYTHMIC DRUGS

      Japanese Journal of Pharmacology
    74. LANE RM; SWEENEY M; HENRY JA
      PHARMACOTHERAPY OF THE DEPRESSED PATIENT WITH CARDIOVASCULAR AND OR CEREBROVASCULAR ILLNESS/

      British journal of clinical practice
    75. HOHNLOSER SH; KLINGENHEBEN T; SINGH BN
      AMIODARONE-ASSOCIATED PROARRHYTHMIC EFFECTS - A REVIEW WITH SPECIAL REFERENCE TO TORSADE-DE-POINTES TACHYCARDIA

      Annals of internal medicine
    76. MYERBURG RJ; KESSLER KM; CHAKKO S; COX MM; FERNANDEZ P; INTERIAN A; CASTELLANOS A
      FUTURE EVALUATION OF ANTIARRHYTHMIC THERAPY

      The American heart journal
    77. KOCHS M; EGGELING T; HOMBACH V
      PHARMACOLOGICAL THERAPY IN CORONARY HEART-DISEASE - PREVENTION OF LIFE-THREATENING VENTRICULAR TACHYARRHYTHMIAS AND SUDDEN CARDIAC DEATH

      European heart journal
    78. GLASSMAN AH; ROOSE SP; BIGGER JT
      THE SAFETY OF TRICYCLIC ANTIDEPRESSANTS IN CARDIAC PATIENTS - RISK-BENEFIT RECONSIDERED

      JAMA, the journal of the American Medical Association
    79. LIP GYH; METCALFE MJ; RAE AP
      MANAGEMENT OF PAROXYSMAL ATRIAL-FIBRILLATION

      Quarterly Journal of Medicine
    80. WILBER DJ; KOPP D; OLSHANSKY B; KALL JG; KINDER C
      NONSUSTAINED VENTRICULAR-TACHYCARDIA AND OTHER HIGH-RISK PREDICTORS FOLLOWING MYOCARDIAL-INFARCTION - IMPLICATIONS FOR PROPHYLACTIC AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR USE

      Progress in cardiovascular diseases
    81. DAVIES RH; DAWKINS KD; SKILLINGTON PD; LEWINGTON V; MONRO JL; LAMB RK; GRAY HH; CONWAY N; ROSS JK; WHITAKER L
      LATE FUNCTIONAL RESULTS AFTER SURGICAL CLOSURE OF ACQUIRED VENTRICULAR SEPTAL-DEFECT

      Journal of thoracic and cardiovascular surgery
    82. CLEMENTY J; CHERADAME I; BORDIER P; GOSSE P; POQUET F
      MECHANISMS OF VENTRICULAR-TACHYCARDIA

      Archives des maladies du coeur et des vaisseaux
    83. MYERBURG RJ; KESSLER KM; CASTELLANOS A
      SUDDEN CARDIAC DEATH - EPIDEMIOLOGY, TRANSIENT RISK, AND INTERVENTIONASSESSMENT

      Annals of internal medicine
    84. PIRES LA; HUANG SKS
      NONSUSTAINED VENTRICULAR-TACHYCARDIA - IDENTIFICATION AND MANAGEMENT OF HIGH-RISK PATIENTS

      The American heart journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 07:13:57